Sorry, you need to enable JavaScript to visit this website.
hamburger overlay

FAQ Listing

No. The lancing device has a uniquely designed and engineered safety mechanism. The release button is depressed and locked in the housing after use.
No. The lancing device is not designed and intended to be used for AST.
Yes. It is suitable for use with children under 1 year of age and neonates.
The lancing device should be disposed of in accordance with your facility’s disposable procedures.
The lancets (needles surrounded by the sterility cap) of the device are sterilized in a process called gamma irradiation which meets the international standards.
If stored properly, the lancets remain sterile for 4 years after sterilization.
If stored properly, the lancing device remains functional for 4 years after sterilization.
No. (For a list of materials please contact Roche Diabetes Care, Mannheim, Germany.)
200 units
In Poland.
Roche Diabetes Care, as a manufacturer of medical devices, certified to European standards, complies with all applicable European directives. The lancing device is CE (Conformité Européene) labeled, which means that the product meets the safety and normative requirements of those European directives. The European regulations are valid and recognized under mutual recognition agreements with many countries, including Canada, LATAM, APAC and Japan. The lancing device also complies with laws such as the US Needlestick Safety and Prevention Act, the TRBA 250 (Germany) or the NR 32 (Brazil) and others.